Guru Ownership Trend
Guru Analysis for Pacira BioSciences, Inc. (PCRX)
Pacira BioSciences, Inc. (PCRX), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $50.28 M.
Top institutional holders include Renaissance Technologies (RenTech) and Jefferies Group.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $3.62 M net outflow during the quarter.
Recent activity highlights Joel Greenblatt who increased their stake by 36.5%. Conversely, Renaissance Technologies (RenTech) reduced exposure by 3.1%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Pacira BioSciences, Inc. (PCRX)
Major holders include Renaissance Technologies (RenTech) ($41.26 M), Jefferies Group ($4.44 M), Cliff Asness ($3.49 M). According to the latest reported data, 4 tracked investment managers collectively hold approximately 2.22 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $3.62 M, with 3 managers increasing positions and 3 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 2 fully exited PCRX. The total reported sell value was $4.82 M.
Yes, 0 managers opened new positions in PCRX, and 3 increased their existing holdings. The total reported buy value was $1.2 M.